Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.99 Analyst target: $8.00 Upside: 704.02%
Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic viral diseases. The company is headquartered in Bothell, Washington.
See the full interactive analysis & chart →Informational only — not investment advice.